Buy Tesamorelin 5mg
FDA-Approved GHRH — Visceral Fat Reduction
Tesamorelin 5mg For Sale — Tesamorelin 5mg — the only FDA-approved growth hormone releasing hormone for visceral fat reduction. Proven to reduce abdominal fat 15-20% at 2mg/day.
- FDA-approved for visceral fat reduction — 15-20% decrease at 2mg/day
- Physiological GH elevation within normal feedback range
- Improves triglyceride and lipid profiles in metabolic syndrome
- Preserves lean mass while reducing visceral fat
- Synergizes powerfully with ghrelin mimetics for amplified GH output
COA verified · US domestic shipping
Tesamorelin 5mg: FDA-Approved Growth Hormone Analog for Visceral Fat Loss
FDA Approved
The only FDA-approved GHRH for visceral fat reduction — based on two Phase III trials demonstrating 15-20% visceral adipose tissue decrease.
Visceral Fat Target
Specifically mobilizes visceral adipose tissue (metabolically dangerous abdominal fat) through GH-mediated lipolysis.
Physiological GH
Stimulates pulsatile GH within the body's own feedback loop — no receptor downregulation or supra-physiological suppression.
Lipid Benefits
Reduces triglycerides and improves lipid profiles alongside visceral fat — addressing multiple cardiovascular risk factors.
The Science Behind Tesamorelin 5mg
Tesamorelin is a synthetic GHRH (Growth Hormone Releasing Hormone) analog with trans-2-hexenoic acid modification that stabilizes it against degradation. The FDA approved it as Egrifta for HIV-associated lipodystrophy, where it reduces visceral adipose tissue 15-20% at 2mg/day — the only approved pharmaceutical for this specific indication.
▸Visceral Fat Mechanism
Tesamorelin stimulates the pituitary to release GH in a pulsatile, physiologically normal pattern. Elevated GH directly increases lipolysis in visceral adipose tissue through hormone-sensitive lipase activation. Unlike direct GH injection (which produces supraphysiological levels), tesamorelin works through the body's own regulatory feedback — producing GH elevation within the physiological range.
▸Clinical Evidence
The FDA approval trials (ENCORE-1 and ENCORE-2) demonstrated 15-20% reduction in visceral adipose tissue area at 2mg/day over 26 weeks. Importantly, visceral fat reduction was maintained only while on tesamorelin — discontinuation led to partial return within 12 weeks. This has led to continuous use protocols in clinical practice.
▸Ipamorelin Synergy
Adding Ipamorelin or GHRP-2 to tesamorelin amplifies GH pulses through dual receptor activation. The Ipamorelin/Tesamorelin blend is a well-established stack for users seeking maximum visceral fat mobilization combined with lean mass preservation.
Complete Tesamorelin 5mg Benefits
- FDA-approved for visceral fat reduction — 15-20% decrease at 2mg/day
- Physiological GH elevation within normal feedback range
- Improves triglyceride and lipid profiles in metabolic syndrome
- Preserves lean mass while reducing visceral fat
- Synergizes powerfully with ghrelin mimetics for amplified GH output
- Reduces cardiovascular risk markers associated with visceral adiposity
Tesamorelin 5mg Dosing Protocol
Clinical Protocol (5mg vial):
• Reconstitute with 2.5mL bacteriostatic water (2mg/mL)
• Dose: 1mL (2mg) subcutaneous daily
• Timing: Before bed (aligns with overnight GH pulse)
• Cycle: 26+ weeks based on FDA trial data
• 5mg vial covers 2.5 days — typically paired with 10mg vials for full protocols
All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available for all products.
Tesamorelin 5mg
COA verified · Third-party tested · US domestic shipping
Buy Now View Stack ProtocolsBody composition peptides optimize the GH/IGF-1 axis and metabolic signaling for simultaneous fat loss and muscle gain.
All Body Composition PeptidesStacks Best With
Stack Tesamorelin 5mg With
Body CompositionIpamorelin 10mg
Selective GHRP for clean GH release without cortisol or prolactin elevation
Buy Ipamorelin 10mg — Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates pulsatile GH release with minimal cortisol, prolactin, or acetylcholine side effects.
Body CompositionSermorelin 5mg
FDA-approved GHRH(1-29) analog for GH optimization and anti-aging
Sermorelin 5mg For Sale — Sermorelin is the first 29 amino acids of GHRH, formerly FDA-approved for pediatric GH deficiency — stimulates pulsatile GH release for anti-aging and body composition without exogenous HGH risks.
Body CompositionTesamorelin 10mg
Extended supply FDA-approved GHRH analog for sustained visceral fat reduction
Verified Tesamorelin 10mg — Tesamorelin 10mg — 5x the single-dose vial, providing 10 days of the FDA clinical dose for extended visceral fat reduction protocols.